Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Computational and Structural Biotechnology Journal|July 1, 2021
Zeta-carbonic anhydrases show CS2 hydrolase activity: A new metabolic carbon acquisition pathway in diatoms?Vincenzo Alterio, Emma Langella, Martina Buonanno, et al.
The Protein Journal|August 10, 2022
Biochemical and Biophysical Characterization of Carbonic Anhydrase VI from Human Milk and SalivaAlma Yrjänäinen, Maarit S Patrikainen, Latifeh Azizi, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Structural Characterization of Thiadiazolesulfonamide Inhibitors Bound to Neisseria gonorrhoeae α-Carbonic AnhydraseAnil Kumar Marapaka, Alessio Nocentini, Molly S Youse, et al.
Journal of Medicinal Chemistry|October 21, 2022
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer CellsLaura Braconi, Elisabetta Teodori, Chiara Riganti, et al.
European Journal of Medicinal Chemistry|December 30, 2018
Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environmentMikhail Krasavin, Anton Shetnev, Tatyana Sharonova, et al.
Journal of Medicinal Chemistry|June 7, 2023
6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors:Alessio Nocentini, Alessandro Bonardi, Carla Bazzicalupi, et al.
European Journal of Medicinal Chemistry|October 10, 2020
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysisMohamed A Abdelrahman, Hany S Ibrahim, Alessio Nocentini, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous BasesAlessio Nocentini, Silvia Bua, Carrie L Lomelino, et al.
International Journal of Molecular Sciences|June 2, 2021
Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective AgentsIrene Bulli, Ilaria Dettori, Elisabetta Coppi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeaeNader S Abutaleb, Ahmed E M Elhassanny, Alessio Nocentini, et al.
Pageof 29